Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 11438
  • 11439
  • 11440
  • …
  • ›
  • »

2025-03-19

Orogen Royalties reports FY results

2025-03-19

Cipher Pharmaceuticals GAAP EPS of $0.13, revenue of $11.82M misses by $0.28M

2025-03-19

4GLOBAL warns of revenue, profit miss amid shift to North America

2025-03-19

PRODWAYS : Implementation of the project to transfer Prodways Group′s listing to Euronext Growth

2025-03-19

Paramount Resources (PRMRF) Upgraded to Buy: What Does It Mean for the Stock?

2025-03-19

Sequana Medical NV GAAP EPS of -€1.22, revenue of €0.106M

2025-03-19

Canfor announces renewal of normal course issuer bid

2025-03-19

PRODWAYS : 2024 results: increase in current EBITDA margin and cash flow from operations

2025-03-19

AUBAY : 2024 annual results: Operating margin from ordinary activities: 9.2% - Net income attributable to owners of the parent: EUR 37.6 million (up 12.7%) - Record net cash: EUR 112 million - Dividend on the rise at EUR 1.30 per share

2025-03-19

Signet Q4 Earnings Beat Estimates, Same-Store Sales Decline Y/Y

2025-03-19

Here′s Why You Should Retain AMED Stock in Your Portfolio Now

2025-03-19

Here′s Why you Should Retain Nevro Stock in Your Portfolio Now

  • «
  • ‹
  • …
  • 11438
  • 11439
  • 11440
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies